echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Cell Industry Conference 2022 conference plan is released: April Shanghai, August Shenzhen, November Wuhan, looking forward to your joining!

    Cell Industry Conference 2022 conference plan is released: April Shanghai, August Shenzhen, November Wuhan, looking forward to your joining!

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    In recent years, modern life sciences and biotechnology have made a series of important advances and major breakthroughs, especially the rapid development of cell therapy technology with stem cells and immune cells as the core, and has been obtained in the clinical research of a variety of refractory diseases.
    Many achievements have shown great application prospects in the future.
    Cell therapy has received unprecedented attention, and relevant policies have been intensively introduced at the national and local levels to support the development of stem cell and immune cell research


    Single-cell sequencing technology came out strongly in 2009.
    Since its development, single-cell sequencing technology has occupied an important application position in tumors, clinical diagnosis, immunology, microbiology, neuroscience and other fields, and is the focus of current research and application

    The scope of research is no longer just genomics and transcriptomics, but expanded to epigenome, spatial transcriptomics, metabolome, immuneomics, and proteomics lineage

    These "multi-omics" techniques allow researchers to more closely observe the heterogeneity between cells and more clearly identify specific cells and their functions


    Cell and gene therapy have changed the way human beings treat genetic diseases and intractable diseases, and are leveraging the entire pharmaceutical ecosystem
    Driven by the needs of various indications, cell and gene therapy are developing rapidly.
    A variety of cellular immunotherapy, stem cell therapy, and gene therapy based on adeno-associated virus and lentiviral vectors have come out one after another, which is for relapsed and refractory tumors and serious genes.
    Genetic defect diseases provide important treatment options

    With the approval of CAR-T immune cell therapy internationally and domestically, cell and gene therapy has entered a new track, and the entire industry has entered a technological breakthrough and rapid industrialization


    2022 Cell Industry Conference 2022 The 8th (Shanghai) Cell and Tumor Precision Medicine Summit Forum will be held in Shanghai in April.
    This summit will closely focus on policy regulations, supervision, process and industrialization progress, stem cell preclinical research and clinical application transformation , Stem cell storage and therapy, tumor immunotherapy, cell and gene therapy, universal CAR-T cell therapy, single cell multi-omics, single cell sequencing, extracellular vesicle isolation and detection, 3D cell culture and organoids, gene therapy And oncolytic viruses, solid tumor treatment and drug development, clinical research and treatment progress and other topics, specially invited from national drug review and regulatory agencies, scientific research institutes, medical institutions, innovative pharmaceutical companies, biotherapy, biotechnology and service companies, Authoritative experts from upstream and downstream enterprises in the industrial chain, industrial parks, investment institutions, and industry associations share exchanges and product displays with industry pioneers

    The organizing committee wholeheartedly builds a high-quality dialogue and cooperation platform, and sincerely invites you to gather in Shanghai in April for the grand event!

    Conference website:

    https:// >


    Summit on Stem Cell Clinical Research and Transformation Application

    Leaders Summit on the Transformation of Tumor Immunotherapy Industry

    Summit on Single Cell Multi-omics Research and Clinical Application

    Cell and Gene Therapy Frontier Technology Application Summit

    3D cell culture and organoid clinical application summit

    * The final agenda is subject to the scene, and the speaking companies can make their own topics

    Guests to be invited (in no particular order)

    Chen Guoqiang, Academician of Chinese Academy of Sciences

    Meng Shufang, Researcher, Cell Room, China Food and Drug Control Research Institute for Biological Products

    Wu Zhaohui, Vice Chairman of China Medical Biotechnology Association

    Han Weidong, Director of the Department of Biotherapy, Chinese People's Liberation Army General Hospital

    Mao Hongju, Shanghai Institute of Microbial Systems and Information Technology, Chinese Academy of Sciences

    Liu Xingguo, Researcher, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences

    Wang Ran, Associate Researcher, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences

    Tang Fuchou, Professor of BIOPIC Center, School of Life Sciences, Peking University, Deputy Director of Beijing Future Genetic Diagnosis High-precision Innovation Center

    Wang Yaohe, Director of China National Cell and Gene Therapy International Joint Research Center

    Su Bing, Professor of Shanghai Institute of Immunology, School of Medicine, Shanghai Jiaotong University

    Liu Baochi, Professor of Shanghai Public Health Clinical Center

    Liu Zhongmin, Dean of Dongfang Hospital Affiliated to Tongji University

    Lin Xinhua, Executive Dean, School of Life Sciences, Fudan University, Director of the Institute of Genetics, Director of the State Key Laboratory of Genetic Engineering

    Yin Zhinan, Dean of the Institute of Translational Medicine, Jinan University

    Liu Yan, Deputy Director and Distinguished Professor of the Institute of Stem Cell and Neural Regeneration, School of Pharmacy, Nanjing Medical University

    Chen Zaozao, Suzhou Institute of Medical Devices, Southeast University

    Sun Wei, National Distinguished Professor, Department of Mechanical Engineering, Tsinghua University

    He Kangxin, the First Affiliated Hospital of Zhejiang University School of Medicine

    Yang Chaoyong, Deputy Dean of the Institute of Molecular Medicine, Shanghai Jiaotong University

    Xin Zou, PhD in Statistical Signal Processing, University of Birmingham, UK, Head of Bioinformatics Platform and Associate Researcher of Jinshan Hospital Affiliated to Fudan University

    Wu Weizhong, Director of the Laboratory of Liver Cancer Research Institute, Zhongshan Hospital, Fudan University

    Pei Duanqing, Professor of West Lake University

    Shi Yufang, Professor of Soochow University

    Li Bin, researcher at Shanghai Institute of Immunology

    More guests are invited, and all units are welcome to recommend themselves!

    *Finally subject to the scene

    Who will participate

    2021 event review

    The 2021 Cell Industry Conference 2021 6th (Shanghai) Cell and Tumor Precision Medicine Summit Forum, accompanied by a two-day conference and a three-day exhibition, will be held at the Shanghai Exhibition Center (1000 Yan'an Middle Road, Jing'an District, Shanghai) on April 25th.
    The conference gathered 60+ industry leaders to share their wonderful speeches.
    There were more than 1,800 people who visited the conference.
    More than 100 high-quality exhibitors and more than 60 industry media attended the conference, presenting a feast of close integration of academic and industry

    The mature "meeting + exhibition" model of the Cell Industry Conference has won unanimous praise from the guests, exhibitors and representatives!

    Gallery of Shanghai Conference on April 23-25, 2021

    2021 Cell Industry Conference 2021 Seventh (Shenzhen) Cell and Tumor Precision Medicine Summit Forum/2021 Gene and Precision Diagnosis and Treatment (Shenzhen) Summit Forum/2021 Tumor Precision Diagnosis and Treatment (Shenzhen) Forum accompanied by a two-day conference and exhibition in October The curtain came to an end at the Shenzhen Convention and Exhibition Center on the 27th! During the special period of the epidemic, this conference adopted a combination of “online (about 120,000 people watching) + offline (more than 600 participants)”.
    The experts shared industry trends from a professional perspective and strategically Discuss the development of the industry and discuss the future development of cell therapy, gene therapy and tumor precision diagnosis and treatment!

    Photo Gallery of Shenzhen Conference on October 26-27, 2021

    Upcoming Events

    2022 Cell Industry Conference

    2022 The 9th (Shenzhen) Cell and Tumor Precision Medicine Summit Forum

    Time: August 2022

    Location: Shenzhen

    2022 Cell Industry Conference

    2022 10th (Wuhan) Cell and Tumor Precision Medicine Summit Forum

    Time: November 2022

    Location: Wuhan

    Sponsors/cooperative media are recruiting, welcome to write to 695114062@qq.
    com for communication


    Conference consultation: Li Yang 17717078907 (same number on WeChat)

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.